Noninvasive molecular imaging of interferon beta activation in mouse liver

Liver International

Volumn 32, Issue 3, 2012, Pages 383-391

  Zhou, Yong ^a   Yan, Shao Duo ^a   Jia, Shuai Zheng ^a   Wang, Hai Ping ^a   Fu, Qiu Xia ^a   Du, Juan ^a   Wang, Xiao Hui ^a   Liang, Sheng Qiang ^b   Zhang, Jin Gang ^a   Zhan, Lin Sheng ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Digestive Endoscopy Center of Nanjing Military Command   (China)

Author keywords

Animal model; Bioluminescence imaging; Hydrodynamic injection; Integrase; Interferon beta; Mouse hepatitis virus type 3

Indexed keywords

BETA INTERFERON; FIREFLY LUCIFERASE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEINASE; VIRUS ENZYME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENE ACTIVITY; HYDRODYNAMICS; INTEGRATION; INTERFERON PRODUCTION; LIVER; LIVER CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEPATOCYTES; IMMUNITY, INNATE; INTERFERON-BETA; LIVER; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; MOLECULAR IMAGING; POLY I-C; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84856679590     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02733.x     Document Type: Article

References (33)

1. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006; 312: 879-82.
2. Dunn GP, Bruce AT, Sheehan KC, et al. A critical function for type I interferons in cancer immunoediting. Nat Immunol 2005; 6: 722-9.
3. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138: 576-91.
4. Ablasser A, Bauernfeind F, Hartmann G, et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009; 10: 1065-72.
5. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778-809.
6. Zohari S, Munir M, Metreveli G, Belak S, Berg M. Differences in the ability to suppress interferon beta production between allele A and allele B NS1 proteins from H10 influenza A viruses. Virol J 2010; 7: 376-84.
7. Kang SM, Won SJ, Lee GH, Lim YS, Hwang SB. Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment. FEBS Lett 2010; 584: 4069-76.
8. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7: 131-7.
9. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005; 102: 17717-22.
10. Andrejeva J, Childs KS, Young DF, et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004; 101: 17264-9.
11. Xu LG, Wang YY, Han KJ, et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005; 19: 727-40.
12. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122: 669-82.
13. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437: 1167-72.
14. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6: 981-8.
15. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27: 147-63.
16. Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47: 729-36.
17. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006; 43(2 Suppl. 1): S54-62.
18. Lienenklaus S, Cornitescu M, Zietara N, et al. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol 2009; 183: 3229-36.
19. Suda T, Liu D. Hydrodynamic gene delivery: its principles and applications. Mol Ther 2007; 15: 2063-9.
20. Song YK, Liu F, Zhang G, Liu D. Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA. Methods Enzymol 2002; 346: 92-105.
21. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-66.
22. Roth-Cross JK, Martinez-Sobrido L, Scott EP, Garcia-Sastre A, Weiss SR. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol 2007; 81: 7189-99.
23. Zhou H, Perlman S. Mouse hepatitis virus does not induce Beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J Virol 2007; 81: 568-74.
24. Schindler L, Engler H, Kirchner H. Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect Immun 1982; 35: 869-73.
25. Groth AC, Olivares EC, Thyagarajan B, Calos MP. A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci U S A 2000; 97: 5995-6000.
26. Raymond CS, Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2007; 2: e162.
27. Virelizier JL, Allison AC. Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures. Arch Virol 1976; 50: 279-85.
28. Olivares EC, Hollis RP, Chalberg TW, et al. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 2002; 20: 1124-8.
29. Loo YM, Owen DM, Li K, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 2006; 103: 6001-6.
30. Cheng G, Zhong J, Chisari FV. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 2006; 103: 8499-504.
31. Boy AL, Zhai Z, Habring-Muller A, et al. Vectors for efficient and high-throughput construction of fluorescent drosophila reporters using the PhiC31 site-specific integration system. Genesis 2010; 48: 452-6.
32. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-7.
33. Ahlen G, Derk E, Weiland M, et al. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes. Gut 2009; 58: 560-9.